Literature DB >> 16679445

Update in diffuse parenchymal lung diseases 2005.

Fernando J Martinez1, Michael P Keane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679445     DOI: 10.1164/rccm.2601011

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.

Authors:  David J Lederer; Selim M Arcasoy; Jessie S Wilt; Frank D'Ovidio; Joshua R Sonett; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2006-06-15       Impact factor: 21.405

2.  Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis.

Authors:  Christopher P Baran; Judy M Opalek; Sara McMaken; Christie A Newland; James M O'Brien; Melissa G Hunter; Benjamin D Bringardner; Martha M Monick; David R Brigstock; Paul C Stromberg; Gary W Hunninghake; Clay B Marsh
Journal:  Am J Respir Crit Care Med       Date:  2007-04-12       Impact factor: 21.405

Review 3.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

Review 4.  Vitamin D deficiency and chronic lung disease.

Authors:  Christopher R Gilbert; Seth M Arum; Cecilia M Smith
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

5.  Case-based discussion: Lymphocytic interstitial pneumonia a rare presentation in an immunocompetent adult male.

Authors:  Ajay Chitnis; Pradeep Kumar Vyas; Priyanka Chaudhary; Gaurav Ghatavat
Journal:  Lung India       Date:  2015 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.